- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03108430
Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation (PrevAsPI-Obs)
April 5, 2017 updated by: Centre Hospitalier Universitaire, Amiens
Inhalation pneumonia (PI) is common in clinical practice but is rarely studied.
For example, there are no data on the incidence of pneumonia after inhalation and risk factors or protective factors to develop one since it is known that anyone who inhaled does not necessarily develop an IP.
There is no data on the benefit of treating inhalation by antibiotic therapy pre-emptively although this practice is common.
In this context, this observational study wishes to take stock of the situation on the subject in order to determine what actions to implement to prevent IP.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jean-Philippe LANOIX, Dr
- Email: lanoix.jean-philippe@chu-amiens.fr
Study Locations
-
-
Picardie
-
Amiens, Picardie, France, 80054
- Recruiting
- CHU Amiens Picardie
-
Contact:
- Jean-Philippe LANOIX, Dr
- Email: lanoix.jean-philippe@chu-amiens.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Observation of inhalations in medicine and resuscitation and collection of data likely to influence the emergence of an IP.
Description
Inclusion Criteria:
- In intensive care: Any intubated patient who presented:
- It is a coma with GCS ≤ 12 without VAS protection, whatever the duration
- Either a proven inhalation, defined by the presence in the VAS of gastric fluid or food
- Either a suspected inhalation, defined by the extrahospital anamnesis
- In medicine :
- Any wrong way (defined by a reflex cough when taking food)
- Coma without intubation, regardless of duration or depth
Exclusion Criteria:
- Patients with VAP
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Inhalation pneumonia
|
Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.
|
Proven inhalations
|
Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.
|
Suspected inhalations (coma + anamnesis)
|
Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 22, 2016
Primary Completion (ANTICIPATED)
August 21, 2017
Study Completion (ANTICIPATED)
August 21, 2017
Study Registration Dates
First Submitted
March 31, 2017
First Submitted That Met QC Criteria
April 5, 2017
First Posted (ACTUAL)
April 11, 2017
Study Record Updates
Last Update Posted (ACTUAL)
April 11, 2017
Last Update Submitted That Met QC Criteria
April 5, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RNI2016-10
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Risk Factor
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
Assistance Publique - Hôpitaux de ParisDirection Générale de l'Offre de SoinsCompleted
-
University Hospital, BrestRecruiting
-
University Hospitals Cleveland Medical CenterRecruitingCardiovascular Risk FactorUnited States
-
Northwestern UniversityNorthShore University HealthSystem; Case Western Reserve University; Shirley... and other collaboratorsCompleted
-
University of ArizonaTerminatedCardiovascular Risk FactorUnited States
-
Penn State UniversityCompletedCardiovascular Risk FactorUnited States
-
Clinique BizetCompleted
-
University Hospital, BrestCompleted
-
University of DelawareCompleted
Clinical Trials on Risk factors and incidence of IP after inhalation
-
Hospices Civils de LyonCompletedSeizures | Hyponatremia | BronchiolitisFrance
-
Anna NordströmUmeå UniversityUnknownCardiovascular Diseases | Cancer | Fracture
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknown
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruiting
-
Gangnam Severance HospitalUnknownPeritoneal Carcinomatosis | Advanced Gastric CancerKorea, Republic of
-
Turkish Neonatal SocietyCompletedNecrotizing EnterocolitisTurkey
-
Green Signal Biopharma Private LimitedCompleted
-
hadeer ehabCompletedInappropriate Prescribing | Clinical Oncology
-
Bristol-Myers SquibbCompletedCrohn's DiseasePoland, United States, France, Belgium, Israel, Hungary, South Africa, Puerto Rico
-
Lawrence Livermore National Laboratory at University...National Cancer Institute (NCI)UnknownProstate CancerUnited States